|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamamoto H, Ngan CY and Monden M: Cancer
cells survive with survivin. Cancer Sci. 99:1709–1714. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li F, Ambrosini G, Chu EY, Plescia J,
Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and
mitotic spindle checkpoint by survivin. 396:580–584. 1998.
|
|
6
|
Jäättelä M: Escaping cell death: Survival
proteins in cancer. Exp Cell Res. 248:30–43. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Adida C, Berrebi D, Peuchmaur M,
Reyes-Mugica M and Altieri DC: Anti-apoptosis gene, survivin, and
prognosis of neuroblastoma. Lancet. 351:882–883. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kawasaki H, Altieri DC, Lu C-D, Toyoda M,
Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin
predicts shorter survival rates in colorectal cancer. Cancer Res.
58:5071–5074. 1998.PubMed/NCBI
|
|
9
|
Monzó M, Rosell R, Felip E, Astudillo J,
Sánchez JJ, Maestre J, Martín C, Font A, Barnadas A and Abad A: A
novel anti-apoptosis gene: Re-expression of survivin messenger RNA
as a prognosis marker in non-small-cell lung cancers. J Clin Oncol.
17:2100–2104. 1999.PubMed/NCBI
|
|
10
|
Swana HS, Grossman D, Anthony JN, Weiss RM
and Altieri DC: Tumor content of the antiapoptosis molecule
survivin and recurrence of bladder cancer. N Engl J Med.
341:452–453. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sarela AI, Macadam RC, Farmery SM, Markham
AF and Guillou PJ: Expression of the antiapoptosis gene, survivin,
predicts death from recurrent colorectal carcinoma. Gut.
46:645–650. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kato J, Kuwabara Y, Mitani M, Shinoda N,
Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, et al:
Expression of survivin in esophageal cancer: Correlation with the
prognosis and response to chemotherapy. Int J Cancer. 95:92–95.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH,
Cho MS and Kim TY: Expression of survivin and clinical correlation
in patients with breast cancer. Biomed Pharmacother. 60:289–292.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin S, Sung B-J, Cho Y-S, Kim HJ, Ha NC,
Hwang JI, Chung CW, Jung YK and Oh BH: An anti-apoptotic protein
human survivin is a direct inhibitor of caspase-3 and -7.
Biochemistry. 40:1117–1123. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Adamkov M, Kajo K, Vybohova D, Krajcovic
J, Stuller F and Rajcani J: Correlations of survivin expression
with clinicomor-phological parameters and hormonal receptor status
in breast ductal carcinoma. Neoplasma. 59:30–37. 2012. View Article : Google Scholar
|
|
16
|
Sui L, Dong Y, Ohno M, Watanabe Y,
Sugimoto K and Tokuda M: Survivin expression and its correlation
with cell proliferation and prognosis in epithelial ovarian tumors.
Int J Oncol. 21:315–320. 2002.PubMed/NCBI
|
|
17
|
Tanaka K, Iwamoto S, Gon G, Nohara T,
Iwamoto M and Tanigawa N: Expression of survivin and its
relationship to loss of apoptosis in breast carcinomas. Clin Cancer
Res. 6:127–134. 2000.PubMed/NCBI
|
|
18
|
Zaffaroni N, Pennati M, Colella G, Perego
P, Supino R, Gatti L, Pilotti S, Zunino F and Daidone MG:
Expression of the anti-apoptotic gene survivin correlates with
taxol resistance in human ovarian cancer. Cell Mol Life Sci.
59:1406–1412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mehrotra S, Languino LR, Raskett CM,
Mercurio AM, Dohi T and Altieri DC: IAP regulation of metastasis.
Cancer Cell. 17:53–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yano J, Hirabayashi K, Nakagawa S,
Yamaguchi T, Nogawa M, Kashimori I, Naito H, Kitagawa H, Ishiyama
K, Ohgi T, et al: Antitumor activity of small interfering
RNA/cationic liposome complex in mouse models of cancer. Clin
Cancer Res. 10:7721–7726. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Akhtar J, Wang Z, Yu C and Zhang ZP:
Effectiveness of local injection of lentivirus-delivered stathmin1
and stathmin1 shRNA in human gastric cancer xenograft mouse. J
Gastroenterol Hepatol. 29:1685–1691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akhtar J, Wang Z, Zhang ZP and Bi MM:
Lentiviral-mediated RNA interference targeting stathmin1 gene in
human gastric cancer cells inhibits proliferation in vitro and
tumor growth in vivo. J Transl Med. 11:2122013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs
BS, Lindner DJ and Borden EC: Downregulation of Bcl-2, FLIP or IAPs
(XIAP and survivin) by siRNAs sensitizes resistant melanoma cells
to Apo2L/TRAIL-induced apoptosis. Cell Death Differ. 11:915–923.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 8:61–70. 2008.
View Article : Google Scholar
|
|
25
|
Lens SMA, Wolthuis RMF, Klompmaker R, Kauw
J, Agami R, Brummelkamp T, Kops G and Medema RH: Survivin is
required for a sustained spindle checkpoint arrest in response to
lack of tension. EMBO J. 22:2934–2947. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang D, Welm A and Bishop JM: Cell
division and cell survival in the absence of survivin. Proc Natl
Acad Sci USA. 101:15100–15105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Altieri DC: Validating survivin as a
cancer therapeutic target. Nat Rev Cancer. 3:46–54. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu CM, Zhu YK, Ma YH, Zhang M, Liao B, Wu
HY and Lin HL: Knockdown of survivin gene by vector-based short
hairpin RNA technique induces apoptosis and growth inhibition in
Burkitt’s lymphoma Raji cell line. Neoplasma. 53:206–212. 2006.
|
|
29
|
Yang J, Ouyang J, Ouyang L, Ouyang L and
Chen Y: Inhibition of cell proliferation and increase of
chemosensitivity by simultaneous knockdown of XIAP and survivin in
pancreatic carcinoma cells. Oncol Res. 21:43–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
31
|
Guan HT, Xue XH, Wang XJ, Li A and Qin ZY:
Knockdown of survivin expression by small interfering RNA
suppresses proliferation of two human cancer cell lines. Chin Med
Sci J. 21:115–119. 2006.PubMed/NCBI
|
